A carregar...
Moderately decreased cholesterol absorption rates are associated with a large atheroprotective effect
OBJECTIVE: Human treatment with ezetimibe results in a moderate 50–54% decrease in cholesterol absorption and a 15–20% decrease in plasma LDL-cholesterol levels; nevertheless, the efficacy of ezetimibe therapy has been recently challenged by the ENHANCE trial. We examined the efficacy of a moderate...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2766672/ https://ncbi.nlm.nih.gov/pubmed/19661480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.109.194605 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|